Synta Announces Initiation Of I-SPY 2 TRIAL Of Ganetespib In Breast Cancer
October 29, 2014 at 07:01 AM EDT
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the initiation of the I-SPY 2 TRIAL (Investigation of Serial Studies to ...